Skip to main content

Table 5 Conditioning regimens for multiple myeloma and lymphoma

From: The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

Conditioning regimen

Drug

Dose

Schedule(day)

Indications

BEAM

BCNU

300 mg/m2

− 6

Lymphoma

Vp16

800 mg/m2

− 5 to − 2

Ara-C

800 mg/kg

− 5 to − 2

Mel

140 mg/m2

− 1

Flu/MEL

Flu

150 mg/m2

− 7 to − 3

Multiple myeloma

Mel

140 mg/m2

− 2, − 1

Bortizomib

  

Flu/Bu

Flu

150 mg/m2

− 10 to − 6

Multiple myeloma

 

Bu

6.4 to 9.6 mg/kg(po)

− 7 to − 4

  1. BCNU, carmustine; VP16, etoposide; Ara-C, cytarabine; Mel, melphan; Flu, fludarabine; Bu, busulfan; allo-HSCT, allogeneic hematological stem cell transplantation